Daiwa Securities Group Inc. Sells 6,691 Shares of Xylem Inc. $XYL

Daiwa Securities Group Inc. cut its holdings in Xylem Inc. (NYSE:XYL) by 7.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 77,875 shares of the industrial products company’s stock after selling 6,691 shares during the period. Daiwa Securities Group Inc.’s holdings in Xylem were worth $10,605,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. TD Asset Management Inc boosted its holdings in Xylem by 1.7% in the fourth quarter. TD Asset Management Inc now owns 91,612 shares of the industrial products company’s stock worth $12,476,000 after purchasing an additional 1,529 shares in the last quarter. Cibc World Market Inc. boosted its holdings in Xylem by 40.6% in the fourth quarter. Cibc World Market Inc. now owns 48,851 shares of the industrial products company’s stock worth $6,653,000 after purchasing an additional 14,104 shares in the last quarter. Lido Advisors LLC boosted its holdings in Xylem by 3.5% in the fourth quarter. Lido Advisors LLC now owns 7,175 shares of the industrial products company’s stock worth $1,053,000 after purchasing an additional 242 shares in the last quarter. Nvest Financial LLC boosted its holdings in Xylem by 81.4% in the fourth quarter. Nvest Financial LLC now owns 4,348 shares of the industrial products company’s stock worth $592,000 after purchasing an additional 1,951 shares in the last quarter. Finally, CIBC Asset Management Inc boosted its holdings in Xylem by 70.1% in the fourth quarter. CIBC Asset Management Inc now owns 57,608 shares of the industrial products company’s stock worth $7,845,000 after purchasing an additional 23,732 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Down 0.3%

NYSE XYL opened at $109.84 on Friday. Xylem Inc. has a twelve month low of $105.29 and a twelve month high of $154.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The stock has a market cap of $26.11 billion, a PE ratio of 27.32, a PEG ratio of 1.56 and a beta of 1.04. The firm has a 50-day simple moving average of $116.75 and a 200 day simple moving average of $128.41.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.09 by $0.03. The business had revenue of $2.13 billion for the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.Xylem’s revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, research analysts forecast that Xylem Inc. will post 5.51 EPS for the current year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date of this dividend is Thursday, May 28th. Xylem’s payout ratio is currently 42.79%.

Xylem announced that its board has initiated a share buyback plan on Wednesday, February 25th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.

Analysts Set New Price Targets

XYL has been the subject of a number of recent research reports. Citigroup decreased their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Barclays decreased their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. Weiss Ratings cut shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Oppenheimer decreased their price target on shares of Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th. Finally, Royal Bank Of Canada decreased their price target on shares of Xylem from $176.00 to $162.00 and set an “outperform” rating for the company in a report on Wednesday, February 11th. Seven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $152.77.

Insider Transactions at Xylem

In other news, Director Jerome A. Peribere acquired 1,210 shares of the stock in a transaction dated Monday, May 4th. The shares were bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the purchase, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.32% of the stock is currently owned by insiders.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.